BigHat Biosciences 医疗技术 医疗健康 生物技术 抗体药物 蛋白质工程 所属公司:BigHat Biosciences, Inc. 当前融资轮次:B轮 成立日期:2019-01-01 所属地:美国 简介:BigHat Biosciences是一个AI蛋白质治疗设计平台,该平台用于将抗体表征实验室与机器学习技术集成在一起,以工程改造具有更复杂功能和更好生物物理特性...
BigHat Biosciences 是一家拥有人工智能/机器学习引导的抗体发现和开发平台的生物技术公司,宣布与强生公司旗下杨森生物技术公司 (Janssen Biotech Inc.) 合作。这项战略合作将强生公司的药物发现、临床开发和数据科学专业知识与 BigHat 的 Milliner 平台(一套与高速湿实验室集成的机器学习技术)相结合,指导高质量抗体的...
About BigHat Biosciences, Inc. Founded in 2019, BigHat Biosciences is an early-stage biotechnology company in the San Francisco Bay Area. BigHat is led by a team of experts spanning machine learning, molecular biology, drug development, and medicine. BigHat is supported by a ...
a Lonza company (SWX:LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to BigHat Biosciences, Inc. (“BigHat”...
Synaffix B.V., a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announced that it has licensed its ADC technology to B...